NEW YORK (GenomeWeb News) – UCB today announced a collaboration with researchers at Harvard to study the human microbiome in the intestine.

The project, for which UCB is providing up to $4.5 million in funding over three years, will classify new species found in the human microbiome and study their impact on the immune system. The goal is to identify new drugs for preventing and/or treating immunological diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.